Brief: Cipla Q4 Consol Net Profit 5.55 Billion Rupees
13/05/2026 08:08
May 13 (Reuters) - Cipla Ltd CIPL.NS: Q4 CONSOL NET PROFIT 5.55 BILLION RUPEES; IBES EST. 7.05 BILLION RUPEES Q4 CONSOL TOTAL REV FROM OPS 65.41 BLN RUPEES, IBES EST. 67.49 BLN RUPEES DIVIDEND 13 RUPEES PER SHR Source text: ID:nnAZN4SVY4O Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate